Ellume Recalls COVID-19 Home Test for Potential False-Positive Results
Ellume has recalled its COVID-19 Home Test for potential false-positive results. The FDA has listed this recall as Class 1, it’s most serious category.
Read MorePosted by Chris Wolski | Nov 16, 2021 | Covid 19, POC Reagents & Test Kits |
Ellume has recalled its COVID-19 Home Test for potential false-positive results. The FDA has listed this recall as Class 1, it’s most serious category.
Read MorePosted by Chris Wolski | Nov 11, 2021 | Covid 19 |
Researchers have found that a breath test for rapid screening is highly accurate in identifying COVID-19 infections in critically ill patients.
Read MorePosted by Chris Wolski | Nov 10, 2021 | Covid 19, POC Rapid Assays |
The FDA reissued the EUA for the BinaxNOW COVID-19 Antigen Self Test as a single test without a prescription for people with COVID-19 symptoms.
Read MorePosted by Chris Wolski | Nov 10, 2021 | Covid 19 |
GENETWORx provides on-site testing options for U.S. businesses that will require unvaccinated workers to submit to weekly testing for the COVID-19 virus.
Read MorePosted by Chris Wolski | Nov 5, 2021 | Covid 19, POC Rapid Assays |
The FDA has issued an EUA for the SPERA COVID-19 Ag Test, a rapid lateral flow immunoassay from Xtrava Health designed for use at the point of care.
Read More